Clinical Trials Browser

Phase 2 × Stomach Neoplasms × halofantrine × Clear all

NCT02015169 2018-01-17

Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver Metastasis

Phase 2 Completed

Gastrointestinal

Stomach Neoplasms